Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-22

FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for granisetron hydrochloride from Natco Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Granisetron hydrochloride (granisetron hydrochloride)

Snippet

SUPPL AP for GRANISETRON HYDROCHLORIDE (GRANISETRON HYDROCHLORIDE)